Subscribe to RSS
DOI: 10.5999/aps.2013.40.2.123
Risk Factors of Treatment Failure in Diabetic Foot Ulcer Patients
Background Some diabetic feet heal without complication, but others undergo amputation due to progressive wounds. This study investigates the risk factors for amputation of diabetic feet.
Methods A total of 55 patients who visited our institution from 2008 to 2012 were included in the study. The patients with abnormal fasting blood sugar levels, lower leg vascularity, and poor nutrition were excluded from the study group, and the wound states were unified. The patients were categorized into a treatment success group (n=47) and a treatment failure group (n=8), and their hemoglobin A1C (HgA1C), C-reactive protein (CRP), white blood cell count (WBC), and serum creatinine levels were analyzed.
Results The initial CRP, WBC, and serum creatinine levels in the treatment failure group were significantly higher than that of the treatment success group, and the initial HgA1C level was significantly higher in the treatment success group. The CRP and WBC levels of both groups changed significantly as time passed, but their serum creatinine levels did not.
Conclusions The initial CRP, WBC, and serum creatinine levels were considered to be risk factors for amputation. Among them, the serum creatinine level was found to be the most important predictive risk factor. Because serum creatinine represents the renal function, thorough care is needed for the feet of diabetic patients with renal impairment.
This article was presented at the 2nd Research and Reconstructive Forum on June 1-2, 2012 in Gwangju, Korea.
Publication History
Received: 27 November 2012
Accepted: 02 January 2013
Article published online:
01 May 2022
© 2013. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
REFERENCES
- 1 Danaei G, Finucane MM, Lu Y. et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378: 31-40
- 2 Heo KB, Kim SM, Jang WI. et al. A clinical study in patients with diabetic gangrene. J Korean Diabetes Assoc 1983; 7: 65-70
- 3 Reiber GE, Boyko EJ, Smith DG. In: Harris MI, Cowie CC, Stern MP. et al. Lower extremity foot ulcers and amputation in individuals with diabetes. Diabetes in America. 1995. 2nd ed. Washington, DC: National Institute of Diabetes and Digestive and Kidney Diseases; 408-428
- 4 Reiber GE. In: Bowker JH, Pfeifer MA. Epidemiology of foot ulcers and amputations in the diabetic foot. Levin and O'neal's the diabetic foot. 2001. St. Louis, MO: Mosby; 13-32
- 5 Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990; 13: 513-521
- 6 Sun JH, Tsai JS, Huang CH. et al. Risk factors for lower extremity amputation in diabetic foot disease categorized by Wagner classification. Diabetes Res Clin Pract 2012; 95: 358-363
- 7 Shojaiefard A, Khorgami Z, Larijani B. Independent risk factors for amputation in diabetic foot. Int J Diabetes Dev Ctries 2008; 28: 32-37
- 8 Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int 1997; 18: 716-722
- 9 Yang Y, Ostbye T, Tan SB. et al. Risk factors for lower extremity amputation among patients with diabetes in Singapore. J Diabetes Complications 2011; 25: 382-386
- 10 Karter AJ, Ferrara A, Liu JY. et al. Ethnic disparities in diabetic complications in an insured population. JAMA 2002; 287: 2519-2527
- 11 Real Collado JT, Valls M, Basanta Alario ML. et al. Factors associated with amputation in diabetic patients with foot ulcer. An Med Interna 2001; 18: 59-62
- 12 Resnick HE, Carter EA, Sosenko JM. et al. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care 2004; 27: 1885-1891
- 13 Hennis AJ, Fraser HS, Jonnalagadda R. et al. Explanations for the high risk of diabetes-related amputation in a Caribbean population of black african descent and potential for prevention. Diabetes Care 2004; 27: 2636-2641
- 14 Margolis DJ, Hofstad O, Feldman HI. Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care 2008; 31: 1331-1336
- 15 Akha O, Kashi Z, Makhlough A. Correlation between amputation of diabetic foot and nephropathy. Iran J Kidney Dis 2010; 4: 27-31
- 16 Jeandrot A, Richard JL, Combescure C. et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia 2008; 51: 347-352
- 17 Vanholder R, Ringoir S, Dhondt A. et al. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991; 39: 320-327
- 18 Ringoir S, Schoots A, Vanholder R. Uremic toxins. Kidney Int Suppl 1988; 24: S4-S9
- 19 Chonchol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 2006; 19: 291-296
- 20 Young BA, Maynard C, Reiber G. et al. Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. Diabetes Care 2003; 26: 495-501
- 21 Speckman RA, Frankenfield DL, Roman SH. et al. Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients. Diabetes Care 2004; 27: 2198-2203